Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03927053 · ClinicalTrials.gov registry record
Consequences of Marijuana Use in HIV-infected Youth
A clinical trial of Youth With HIV, sponsored by Duke University.
- Completed
- Registry status
- 21
- Enrollment target
- 2
- Study locations
NCT03927053: Completed study of Youth With HIV, sponsored by Duke University.
NCT03927053 is a study of Youth With HIV that has completed, run by Duke University. The registered enrollment target is 21 participants. The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03927053, a study of Youth With HIV, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
- 2
- Study locations
Study Summary
Proposed study focuses on Youth With HIV (YWH) recruited from the University of North Carolina using a cross sectional assessment of blood samples, clinical, demographic, behavioral, \[including substance use and frequency\], and neurocognitive data will be evaluated from YWH treated before CD4 T cell decline.
Primary Outcome
This is measured by molecular mechanism of chronic macrophage activation.
Conditions Studied
Study Locations (2)
North Carolina
- Duke UMC - Durham
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-10-31 |
| Est. Completion | 2021-10-15 |
What the finished NCT03927053 record still lists
NCT03927053 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 1 condition, with Youth With HIV appearing as the primary indexed condition, and to 0 interventions.
NCT03927053 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03927053 about?
NCT03927053 is a clinical study titled "Consequences of Marijuana Use in HIV-infected Youth". Proposed study focuses on Youth With HIV (YWH) recruited from the University of North Carolina using a cross sectional assessment of blood samples, clinical, demographic, behavioral, \[including substance use and frequency\], and neurocognitive data will be evaluated from YWH treated before CD4 T ce...
What is the current status of trial NCT03927053?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2019-10-31. Estimated completion is 2021-10-15.
What conditions does trial NCT03927053 study?
This clinical trial studies the following conditions: Youth With HIV.
Who is sponsoring clinical trial NCT03927053?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03927053 being conducted?
This trial has 2 study locations across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI